SERES THERAPEUTICS INC's ticker is MCRB and the CUSIP is 81750R102. A total of 155 filers reported holding SERES THERAPEUTICS INC in Q4 2021. The put-call ratio across all filers is 0.81 and the average weighting 0.1%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $119,000 | -50.3% | 50,000 | 0.0% | 0.00% | -100.0% |
| Q2 2023 | $239,500 | -57.8% | 50,000 | -50.0% | 0.00% | -50.0% |
| Q1 2023 | $567,000 | +1.2% | 100,000 | 0.0% | 0.00% | 0.0% |
| Q4 2022 | $560,000 | -12.8% | 100,000 | 0.0% | 0.00% | 0.0% |
| Q3 2022 | $642,000 | +28.9% | 100,000 | +42.9% | 0.00% | +100.0% |
| Q1 2022 | $498,000 | -14.6% | 70,000 | 0.0% | 0.00% | 0.0% |
| Q4 2021 | $583,000 | +39.5% | 70,000 | +16.7% | 0.00% | 0.0% |
| Q3 2021 | $418,000 | -56.2% | 60,000 | +50.0% | 0.00% | -50.0% |
| Q2 2021 | $954,000 | +85.2% | 40,000 | +60.0% | 0.00% | +100.0% |
| Q1 2021 | $515,000 | – | 25,000 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Flagship Pioneering Inc. | 23,117,045 | $129,455,452 | 4.13% |
| Eversept Partners, LP | 2,200,999 | $12,325,594 | 1.08% |
| Kynam Capital Management, LP | 776,662 | $4,349,307 | 0.67% |
| SILVERARC CAPITAL MANAGEMENT, LLC | 374,422 | $2,096,763 | 0.60% |
| Lion Point Capital, LP | 596,803 | $3,109,000 | 0.44% |
| Knott David M Jr | 200,100 | $1,121 | 0.42% |
| FEDERATED HERMES, INC. | 18,085,938 | $101,281,253 | 0.28% |
| Atom Investors LP | 95,520 | $534,912 | 0.27% |
| BOULDER HILL CAPITAL MANAGEMENT LP | 20,200 | $113,120 | 0.09% |
| HARBOURVEST PARTNERS LLC | 49,363 | $276,433 | 0.09% |